Oslo University Hospital: Infections trials

The registry lists 11 Infections studies with Oslo University Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 3Phase 3 4Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Infectious Pseudochromdrosis Caused by Bacillus CereusStatus unknownNCT05507086
• EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform TrialTerminatedNCT04891133Phase 2/3
• Cod Liver Oil for Covid-19 Prevention StudyCompletedNCT04609423Phase 4
• Fecal Transplantation for Primary Clostridium Difficile InfectionTerminatedNCT03796650Phase 3
• Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis CathetersCompletedNCT03392584
• IMT for Primary Clostridium Difficile InfectionTerminatedNCT02301000Phase 2/3
• Mecillinam for Treatment of Genital Chlamydia InfectionTerminatedNCT02083276Phase 2
• The Effect of Probiotics in HIV-1 InfectionCompletedNCT01439841Not applicable
• Local Gentamicin Application to Reduce Postoperative Infection RateCompletedNCT01287780Phase 3
• Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.WithdrawnNCT01151462
• Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee ArthroplastyStatus unknownNCT00423982Phase 4